Cannabis Use: Clinical Trials

152 trials for Cannabis Use, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

65 completed, 37 recruiting, 17 not yet recruiting, 13 unknown. 75 Not applicable, 20 Phase 1, 15 Phase 2, 6 Early Phase 1, 6 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable75Completed 35, Recruiting 19, Not yet recruiting 9, Active not recruiting 4, Unknown 4, Enrolling by invitation 1, Suspended 1, Terminated 1, Withdrawn 1
Phase 120Recruiting 8, Completed 5, Not yet recruiting 5, Unknown 1, Withdrawn 1
Phase 215Completed 5, Recruiting 4, Active not recruiting 1, Not yet recruiting 1, Suspended 1, Terminated 1, Unknown 1, Withdrawn 1
Early Phase 16Not yet recruiting 3, Active not recruiting 1, Completed 1, Unknown 1
Phase 46Completed 3, Recruiting 1, Unknown 1, Withdrawn 1
Phase 32Recruiting 1, Suspended 1

Follow Cannabis Use: new trials by email Literature Review of Cannabis Use trials Research Report on Cannabis Use

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of Cannabidiol on Psychiatric Symptoms, Cognition, and Cannabis Consumption in Cannabis Users With Recent-Onset Psychosis
Cannabidiol (CBD), Placebo - Schizophrenia Spectrum Disorders, Cannabis Use
Phase 2WithdrawnUniversity of Maryland, Baltimore2050-01-012021-04-19
Behavioral Pharmacology of THC and Beta-Myrcene
Placebo, THC, Beta-Myrcene - Cannabis Use
Phase 1Not yet recruitingJohns Hopkins University322027-07-012026-07-31
Transcranial Magnetic Stimulation for Adolescents and Young Adults With Cannabis Use Disorder
Magstim SuperRapid2, Sham rTMS - Cannabis Use, Cannabis Use Disorder
Not applicableNot yet recruitingUniversity of Minnesota502027-03-012026-06-09
Activity-Based Intervention to Address Cannabis Use
Motivational and Behavioral Economics Informed Intervention, Enhanced Usual Care - Cannabis Use
Not applicableNot yet recruitingUniversity of Michigan3002027-02-012026-09-14
Research Investigating Drug Effects-2 (RiDE-2)
Placebo Oral Capsule, THC - Cannabis Use, Substance Use Disorder (SUD)
Early Phase 1Not yet recruitingUniversity of Illinois at Chicago1442027-01-042026-10-22
Clinician Practice Companion to Address Youth Substance Use
Practice Companion - Substance Use, Substance-Related Disorders
Not applicableNot yet recruitingMassachusetts General Hospital602027-01-012026-10-07
Examining the Role of Tolerance on Dose-dependent Effects of Acute THC on Oculomotor and Cognitive Performance
Cannabis - Cannabis Use, Impaired Driving
Phase 1Not yet recruitingJohns Hopkins University402026-12-012026-10-16
Cannabis and Opioid Use Disorder, Study 2
Inhaled Cannabis, Intranasal Opioid - Opioid Use Disorders, Cannabis Use
Phase 1Not yet recruitingUniversity of Kentucky1002026-11-302026-10-09
Cannabis Effects on Opioid Self-Administration
Cannabis, Placebo Cannabis, Intranasal Opioid Agonist - Opioid Use Disorder, Cannabis Use
Phase 1Not yet recruitingShanna Babalonis, PhD302026-11-302026-10-14
Lung Health and Breath Biomarkers: Acute Effects of Inhaled Cannabis
Cannabis (THC), Tobacco Cigarette - Cannabis Use, Tobacco
Early Phase 1Not yet recruitingHannah Harris122026-11-012026-10-06
Developing and Testing an Online Intervention for Alcohol and Cannabis Misuse and Healthy Relationship Skills Among Young Adult Couples
Online, couples-based intervention - Alcohol Drinking, Cannabis Use
Not applicableNot yet recruitingUniversity of Washington602026-10-012026-07-08
vEAET-H for Chronic Pain Patients Using Medical Cannabis in Israel - A Feasibility Study
Group-based virtual Emotional Awareness & Expression Therapy - Hebrew (vEAET-H) - Chronic Musculoskeletal Pain, Cannabis Use
Not applicableRecruitingReuth Rehabilitation Hospital422026-10-012026-07-28
Acute Effects of Cannabis on Cognition and Affect
THC 20mg, Placebo - Cannabis Use
Phase 1RecruitingWashington State University922026-09-112026-10-29
Smart Talk: Cannabis Awareness and Prevention Curriculum Evaluation
Behavioral: Smart Talk Cannabis Awareness and Prevention - Cannabis Use
Not applicableNot yet recruitingStanford University108002026-09-012026-06-08
Wayne State Warriors Marijuana Clinical Research Program: Cannabinoid Adjunct to Prolonged Exposure & Recovery
Cannabidiol (CBD) only, Placebo only, Delta-9-tetrahydrocannabinol (THC) only - PTSD, Post Traumatic Stress Disorder
Phase 1 / Phase 2Not yet recruitingLeslie Lundahl2802026-09-012026-08-26
Brief Family-Based Cannabis Use Intervention for Youth With Early Juvenile Justice Involvement
Brief Family Based Intervention, Parenting Psychoeducation - Cannabis Use, Delinquency
Not applicableNot yet recruitingRhode Island Hospital602026-07-152026-07-14
Feasibility and Acceptability Trial to Reduce Tobacco and Cannabis Use During Pregnancy and Postpartum
Perinatal smoking cessation treatment and maintenance sessions - Perinatal, Cannabis Use
Not applicableRecruitingUniversity of Pittsburgh252026-06-172026-07-06
Neuroimaging of Adolescent Cannabis Use Treatment
Contingency Management, Elastic Net Regression - Cannabis Use, Cannabis Dependence
Not applicableRecruitingIndiana University802026-06-152026-06-22
Perceptions of Proposed Warnings for Cannabis Edibles Packaging
No Warning Control, Delayed Effects Text Only, Delayed Effects Plus Icon - Cannabis Use
Not applicableCompletedWake Forest University Health Sciences12502026-05-272026-10-13
Testing Warning Labels for Retail Cannabis Products Using a Discrete Choice Experiment
Discrete choice experiment (DCE) survey-experiment - Cannabis Use, Risk Perception
Not applicableRecruitingUniversity of Oklahoma4502026-05-192026-07-27

Showing 20 of 152. Sign in to see all of them.

Narrower conditions

Marijuana Abuse (59)  ·  Substance-Related Disorders (12)  ·  Alcohol Drinking (11)  ·  Psychotic Disorders (8)  ·  Schizophrenia (7)  ·  Tobacco Use (7)  ·  Marijuana Use (6)  ·  Adolescent Behavior (5)  ·  Behavior, Addictive (5)  ·  Marijuana Smoking (5)  ·  Alcoholism (4)  ·  Cognitive Dysfunction (4)  ·  Depression (4)  ·  Mental Disorders (4)  ·  Opioid-Related Disorders (4)

Broader conditions

Mental Disorders (77)  ·  Chemically-Induced Disorders (68)  ·  Substance-Related Disorders (57)  ·  Behavior (47)  ·  Pathological Conditions, Signs and Symptoms (20)  ·  Signs and Symptoms (16)  ·  Drinking Behavior (14)  ·  Neurologic Manifestations (13)  ·  Schizophrenia Spectrum and Other Psychotic Disorders (10)  ·  Smoking (9)  ·  Behavioral Symptoms (8)  ·  Nervous System Diseases (6)  ·  Pain (6)  ·  Alcohol-Related Disorders (5)  ·  Compulsive Behavior (5)

Interventions

nabiximols (19)  ·  Dronabinol (16)  ·  Cannabidiol (6)  ·  Ethanol (4)  ·  Exercise (3)  ·  Cognitive Behavioral Therapy (2)  ·  Medical Marijuana (2)  ·  Methods (2)  ·  Therapeutics (2)  ·  Acetylcysteine (1)  ·  Amyloid (1)  ·  Analgesics, Opioid (1)  ·  Blood Specimen Collection (1)  ·  Choline (1)  ·  Choline O-Acetyltransferase (1)

Sponsors

University of Michigan (7)  ·  University of Washington (6)  ·  Johns Hopkins University (5)  ·  Medical University of South Carolina (5)  ·  University of Colorado, Denver (5)  ·  Centre hospitalier de l'Université de Montréal (CHUM) (4)  ·  Duke University (4)  ·  Massachusetts General Hospital (4)  ·  National Institute on Drug Abuse (NIDA) (4)  ·  New York State Psychiatric Institute (4)  ·  University of Colorado, Boulder (4)  ·  Yale University (4)  ·  Centre for Addiction and Mental Health (3)  ·  Wake Forest University Health Sciences (3)  ·  Central Hospital, Nancy, France (2)

Countries

United States (103)  ·  Canada (21)  ·  France (6)  ·  Spain (5)  ·  United Kingdom (4)  ·  Switzerland (3)  ·  Israel (2)  ·  Finland (1)  ·  Germany (1)  ·  Hong Kong (1)  ·  Netherlands (1)  ·  Norway (1)  ·  Turkey (Türkiye) (1)

Top investigators

Beth Reboussin, PhD (3)  ·  Randi M Schuster, PhD (3)  ·  Dustin Lee, PhD (2)  ·  Erin Bonar (2)  ·  Marilyn Huestis, Ph.D. (2)  ·  Shanna Babalonis, PhD (2)  ·  Aimee Aimee McRae-Clark, PharmD (1)  ·  Alan Budney, PHD (1)  ·  Alecia Dager, PhD (1)  ·  Alina I Palimaru, PhD (1)  ·  Amy C Justice, MD, PhD (1)  ·  Ana Gleisner (1)  ·  Andreana Benitez, PhD (1)  ·  Antoinette Burger, PhD (1)  ·  Antoni Gual, MD,PhD (1)

Results publications

PMID 42176349, PMID 27899456, PMID 28138971, PMID 28188235, PMID 28797270, PMID 30408351, PMID 31535597, PMID 33155722, PMID 33242924, PMID 33298281, PMID 33309538, PMID 33322849, PMID 33451073, PMID 34261559, PMID 34276449, PMID 34520807, PMID 34891077, PMID 35032682, PMID 35144238, PMID 35275086, PMID 35709178, PMID 36442441, PMID 36451226, PMID 36493386, PMID 36549747, PMID 36642667, PMID 36750134, PMID 37051014, PMID 37208126, PMID 37271412, PMID 37821096, PMID 38373037, PMID 38416223, PMID 38600496, PMID 39159806, PMID 39380911, PMID 39418443, PMID 39838401, PMID 40702165, PMID 40924271, PMID 40996525, PMID 41411314, PMID 41427816, PMID 41677842, PMID 41733237, PMID 41734366, PMID 41792806, PMID 41820717, PMID 42208065, PMID 42463843

NIH funding

R01DA053209 (3), 2025 (2), R01DA058624 (2), R34DA045712 (2), U54DA016511 (2), 2023 (1), K01DA057395 (1), K01DA058152 (1), K23AA028238 (1), K23AA031034 (1), K23DA045080 (1), K23DA048062 (1), K23DA048132 (1), K23DA050800 (1), K23DA058014 (1)